IE
NTGN

Israel Englander’s Neon Therapeutics, Inc. Common Stock NTGN Stock Holding History

Israel Englander’s Portfolio NTGN Stock Details NTGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-167,117
Closed -$197K – 4845
2019
Q4 		$197K Buy
167,117
+140,892
+537% +$225K ﹤0.01% 3891
2019
Q3 		$45K Buy
+26,225
New +$79.8K ﹤0.01% 4056
2018
Q3 		– Sell
-160,507
Closed -$2.02M – 4474
2018
Q2 		$2.02M Buy
+160,507
New +$2.2M ﹤0.01% 2394

Other funds holding NTGN

TGI
TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Athanor Capital New York $24.6M AUM 2.49% 1-Year Est. Return
HMC
Harvard Management Company Boston, Massachusetts $4.26B AUM 5.81% 1-Year Est. Return
MS
Maven Securities St Helier, Jersey $5.06B AUM 59.27% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Israel Englander's NTGN Position: Q1 2020 in Review

Israel Englander sold out of Neon Therapeutics, Inc. Common Stock (NTGN) in Q1 2020, closing a stake of 167,117 shares — an estimated $197K sold.

Israel Englander first reported a position in NTGN in Q2 2018 and held it in 3 quarters. The position peaked at $2.02M in Q2 2018. 43 funds tracked by Wall St. Rank hold NTGN as of Q1 2020.

  • Israel Englander reported no remaining Neon Therapeutics, Inc. Common Stock position as of Q1 2020 after selling out during the quarter.
  • Israel Englander sold 167,117 Neon Therapeutics, Inc. Common Stock shares in Q1 2020, an estimated $197K.
  • Israel Englander first reported a position in Neon Therapeutics, Inc. Common Stock in Q2 2018 and held it in 3 quarters.
  • Israel Englander's Neon Therapeutics, Inc. Common Stock position peaked at $2.02M in Q2 2018.
  • 43 funds tracked by Wall St. Rank held Neon Therapeutics, Inc. Common Stock as of Q1 2020.

Based on Millennium Management's 13F filing for Q1 2020, filed 14 May 2020.